Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01656954 · ClinicalTrials.gov registry record
Predicting Volume Response Study
A clinical trial of Shock and Hypovolemia, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 7
- Enrollment target
- 1
- Study location
NCT01656954: Completed study of Shock and Hypovolemia, sponsored by University of Pennsylvania.
NCT01656954 is a study of Shock and Hypovolemia that has completed, run by University of Pennsylvania. The registered enrollment target is 7 participants, below the 481-participant average among 9 other Shock trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01656954, a study of Shock and Hypovolemia, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand and document measurements in heart stroke volume (the volume or amount of blood pumped per heart beat) and cardiac output (the volume or amount of blood pumped by your heart per minute) during a passive leg raise maneuver (elevation of the legs), and to determine if these measurements can predict changes in the same as a result of fluid or blood product administration.
Primary Outcome
Stroke volume is measured prior to passive leg raise (PLR)and at 3 minutes after completion of the PLR. Stroke volume is measured at baseline after initiation of fluid/blood administration, every 1 minute for 10 minutes, then every 10 minutes until completion of the administration.
Conditions Studied
Interventions
- PROCEDURE Passive Leg Raise (PLR)
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-04 |
What the finished NCT01656954 record still lists
NCT01656954 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 481-participant average among 9 other Shock trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Shock appearing as the primary indexed condition, and to 1 intervention - of which Passive Leg Raise (PLR) is the first listed.
NCT01656954 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01656954 about?
NCT01656954 is a clinical study titled "Predicting Volume Response Study". The purpose of this study is to understand and document measurements in heart stroke volume (the volume or amount of blood pumped per heart beat) and cardiac output (the volume or amount of blood pumped by your heart per minute) during a passive leg raise maneuver (elevation of the legs), and to det...
What is the current status of trial NCT01656954?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2011-08. Estimated completion is 2014-04.
What conditions does trial NCT01656954 study?
This clinical trial studies the following conditions: Shock, Hypovolemia.
What interventions are being tested in trial NCT01656954?
The interventions under investigation include: Passive Leg Raise (PLR) (PROCEDURE).
Who is sponsoring clinical trial NCT01656954?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01656954 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01656954's enrollment target sits among peer trials
7 10th of 9 the lowest of 9 other Shock trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Shock trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
RECRUITING
-
Resuscitative TEE Collaborative Registry
RECRUITING
-
Evaluating Fluid Responsiveness in ICU Patients Using VTI and Trendelenburg Positioning
RECRUITING · NA
-
Central Line Study
RECRUITING · Phase 4
-
Vasoactive Drugs in Intensive Care Unit
RECRUITING · Phase 4
-
Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia